Sequestration cuts on FDA user fees threaten industry growth

08/8/2013 | Star Tribune (Minneapolis-St. Paul, Minn.)

Subjecting the medical device user fees to sequestration cuts could hinder the FDA from improving the efficiency of its regulatory process, which in turn could impede the growth of medtech companies, according to this opinion piece. The industry already is facing a new tax to help pay for the health care overhaul and should not "be taxed twice by having the user-fee money made unavailable for improved oversight," this article says.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations